Recombinant chimeric anti-CD30 monoclonal antibody-MCC-DM1

Product Name :
Recombinant chimeric anti-CD30 monoclonal antibody-MCC-DM1

Search keywords :
MCC-DM1

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 8

Target Vo Short Name :
CD30

Moa_Name:
Tubulin polymerisation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Crosslink Pharmaceutical R & D Co Ltd

Active Company_Name :
Shanghai Crosslink Pharmaceutical R & D Co Ltd

Active Indication_Name:
Hodgkin Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-CREB (Ser133) Rabbit mAb custom synthesis
Epratuzumab CD22
Glucosidase 2 subunit beta Antibody: Glucosidase 2 subunit beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa., targeting to Glucosidase 2 subunit beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts